Plasma proteomic signature of human longevity
Aging Cell · 2024
DOI: 10.1111/acel.14136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2024. Verfasst von Xiaojuan Liu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Longevity, Proteomics. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NHLBI NIH HHS, NIDA NIH HHS.
Abstract (Originalsprache)
The identification of protein targets that exhibit anti‐aging clinical potential could inform interventions to lengthen the human health span. Most previous proteomics research has been focused on chronological age instead of longevity. We leveraged two large population‐based prospective cohorts with long follow‐ups to evaluate the proteomic signature of longevity defined by survival to 90 years of age. Plasma proteomics was measured using a SOMAscan assay in 3067 participants from the Cardiovascular Health Study (discovery cohort) and 4690 participants from the Age Gene/Environment Susceptibility‐Reykjavik Study (replication cohort). Logistic regression identified 211 significant proteins in the CHS cohort using a Bonferroni‐adjusted threshold, of which 168 were available in the replication cohort and 105 were replicated (corrected p value
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA.
- Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
- Icelandic Heart Association, Kopavogur, Iceland.
- Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington, USA.
- Cardiovascular Health Research Unit, Department of Epidemiology, University of Washington, Seattle, Washington, USA.
ORCID-Profile: Xiaojuan Liu, Lori L Jennings, Michelle C Odden
Förderung
- NIA NIH HHS
- NHLBI NIH HHS
- NIDA NIH HHS
- Althingi (the Icelandic Parliament)
- University of Iceland Research Fund (Eimskip University Fund)
- National Heart, Lung, and Blood Institute
- National Institute on Aging
- Hjartavernd
Zitieren
APA
Liu, X., Axelsson, G. T., Newman, A. B., Psaty, B. M., Boudreau, R. M., Wu, C., Arnold, A. M., Aspelund, T., Austin, T. R., Gardin, J. M., Siggeirsdottir, K., Tracy, R. P., Gerszten, R. E., Launer, L. J., Jennings, L. L., Gudnason, V., Sanders, J. L., & Odden, M. C. (2024). Plasma proteomic signature of human longevity. Aging Cell. https://doi.org/10.1111/acel.14136
Vancouver
Liu X, Axelsson GT, Newman AB, Psaty BM, Boudreau RM, Wu C, et al. Plasma proteomic signature of human longevity. Aging Cell. 2024. doi:10.1111/acel.14136
BibTeX
@article{Liu2024,
author = {Liu, Xiaojuan and Axelsson, Gisli Thor and Newman, Anne B and Psaty, Bruce M and Boudreau, Robert M and Wu, Chenkai and Arnold, Alice M and Aspelund, Thor and Austin, Thomas R and Gardin, Julius M and Siggeirsdottir, Kristin and Tracy, Russell P and Gerszten, Robert E and Launer, Lenore J and Jennings, Lori L and Gudnason, Vilmundur and Sanders, Jason L and Odden, Michelle C},
title = {Plasma proteomic signature of human longevity},
journal = {Aging Cell},
year = {2024},
doi = {10.1111/acel.14136}
}
EUVIMED